Latest Breaking News On - Satisfaction are maintained - Page 1 : comparemela.com

AbbVie today announced that new data from its migraine portfolio will be presented at the Migraine Trust International Symposium (MTIS) 2022, taking place in London from September 8-11.

United kingdomCity ofMegan craigMudra kapoorGlobal medical affairsMigraine trust international symposiumInternational studyFrom abbviesepVice presidentStandard timeAbbvie abstractsPreventive treatmentGlobal resultsPreventive medication failureFunctioning among individualsPreventive treatment failure